Doctor profile · Federal record
Dr. SHRADHA AHUJA, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hospitalist Physician · NEW ORLEANS, LA
- NPI 1578904199
- Accepts Medicare
- MIPS 88.9 / 100 · 2023
- 15 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1401 FOUCHER ST
NEW ORLEANS, LA 701153515
(504) 897-8970
fax (504) 897-8777 - Mailing address
-
3600 PRYTANIA ST STE 35
NEW ORLEANS, LA 701153678
Credentials & registration
- NPI registered
- July 2013 — 13 yrs on file
- Profile last updated
- June 1, 2022
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Louisiana #331087 · Mississippi #24481
- Medicaid (2)
- AL #192170 · MS #06120550
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578904199. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
219
Distinct HCPCS
5
Medicare allowed
$23,512
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 121 | 79 | $96 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 41 | 21 | $141 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 31 | 25 | $96 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 13 | 13 | $179 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 13 | 13 | $65 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 75. This provider delivers 2.9× the peer median.Open Payments
Industry payments received
All-time total
$3,445
Transactions
105
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $905.77 | |
| Celgene Corporation | 6 | $254.49 | |
| AstraZeneca Pharmaceuticals LP | 12 | $236.84 | |
| Merck Sharp & Dohme LLC | 8 | $212.00 | |
| PFIZER INC. | 10 | $182.67 | |
| Janssen Biotech, Inc. | 7 | $160.81 | |
| Daiichi Sankyo Inc. | 5 | $112.76 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $107.58 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $95.15 | |
| Incyte Corporation | 4 | $83.79 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71.56 | |
| Gilead Sciences, Inc. | 4 | $68.56 | |
| Karyopharm Therapeutics Inc. | 3 | $63.19 | |
| Adaptive Biotechnologies Corporation | 2 | $60.17 | |
| Astellas Pharma US Inc | 3 | $56.71 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
323
Patients
81
Total drug cost
$18,636
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 126 | 43 | $2,276 |
| Gabapentin | Generic | 24 | 0 | $415 |
| Ondansetron Hcl | Generic | 24 | 16 | $263 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 20 | 11 | $443 |
| Prednisone | Generic | 16 | 0 | $225 |
| Lidocaine-Prilocaine (Lidocaine/Prilocaine) | Brand | 15 | 11 | $388 |
| Pantoprazole Sodium | Generic | 13 | 0 | $104 |
| Tramadol Hcl | Generic | 13 | 0 | $69 |
| Xarelto (Rivaroxaban) | Brand | 13 | 0 | $13,771 |
| Alprazolam | Generic | 12 | 0 | $85 |